© 2024
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
© 2024
Through advanced bioconjugation
techniques, we accelerate research and
development in areas such as Nanoparticle
Vaccines, Antibody-Drug Conjugates,
and Diagnostic products.
Antibody conjugates, Nanoparticles,
Diagnostics & Sustained delivery. Leverage our
bioconjugation expertise, protein production
capabilities & comprehensive characterization suite
to accelerate your transition from R&D to
commercial product.
Antibody conjugates,
Nanoparticles, Diagnostics, & Sustained delivery.
Leverage our bioconjugation expertise, protein production capabilities and comprehensive characterization suite to accelerate your transition from R&D to commercial product.
Our Capabilities
Site-specific chemistries,
payloads and ready made
conjugates
Explore our bioconjugation toolbox and
Purchase off-the-shelf products
developed for your early stage research.
Structural Characterisation
Using our suite of Chromatographic, Mass Spectrometric and Biophysical instruments we have the capability to monitor, asses and qualify your conjugates
Whether you are looking to make a custom purification column or a specific ADC, leverage our dedicated team to assemble and test your desired product.
Genie Biotech can offer recombinant protein production services from our in-house BSL-2 facility
Our Capabilities
Discover the events we’ve attended and see where we’ll be next…
Discover the events we’ve attended and see where we’ll be next…
Genie Biotech’s paper describing GenieTAG™ technology, and a COVID-19 vaccine candidate has been published.
Karl Dietrich Brune, Ilva Liekniņa, Grigorij Sutov, Alexander R Morris, Gints Kalniņš, Andris Kazāks, Rihards Kluga, Sabine Kastaljana, Anna Zajakina, Juris Jansons, Dace Skrastiņa, Karīna Spunde, Alexander A. Cohen, Pamela J. Bjorkman, Howard R. Morris, Edgars Suna, Kaspars Tārs in ChemBioChem 2021; N-Terminal Modification of Gly-Histagged Proteins with Azidogluconolactone.
Genie Biotech’s paper describing GenieTAG™ technology, and a COVID-19 vaccine candidate has been published.
Karl Dietrich Brune, Ilva Liekniņa, Grigorij Sutov, Alexander R Morris, Gints Kalniņš, Andris Kazāks, Rihards Kluga, Sabine Kastaljana, Anna Zajakina, Juris Jansons, Dace Skrastiņa, Karīna Spunde, Alexander A. Cohen, Pamela J. Bjorkman, Howard R. Morris, Edgars Suna, Kaspars Tārs in ChemBioChem 2021; N-Terminal Modification of Gly-Histagged Proteins with Azidogluconolactone.
